TQB3616

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for TQB3616, covering 2021-12-14 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer [Phase 3]

See pricing